ASSESSMENT FINAL EXAM
COMPLETE QUESTIONS AND
CORRECT DETAILED ANSWERS
WITH STUDY GUIDE AND ACTUAL
EXAM ||ALREADY GRADED A +||
Latest Version 2025-2026
Autosomal Dominant - ANSWER 1 parent has, 50% change of child
having
Autosomal Recessive - ANSWER Both parents are carriers, 25% change
of child having, 50% chance child is a carrier.
Cystic Fibrosis - ANSWER affects pancreas causing secretions in lungs
21st Trisomy - ANSWER Down Syndrome
Klinefelter Syndrome (XXY) - ANSWER male has extra X, female like
qualities
Turner Syndrome - ANSWER Missing X in females
Alpha Thalassemia - ANSWER inherited blood disorder; mild to severe
anemia
Beta Thallasemia - ANSWER low hemoglobin; contraindicated
medication ferrous sulfate
Prevalence Risk - ANSWER proportion of the population affected at a
certain time
Incidence rate - ANSWER number of new cases divided by population
,Innate immunity - ANSWER inflammation; increased vascular
permeability
B&T lymphocytes - ANSWER immune response
primary malignant tumor - ANSWER lack of organization of cells
glucocorticoids - ANSWER used in combination with other agent to treat
lymphoid tissue (leukemia). glucocorticoids are directly toxic to
lymphoid tissues.
Selective estrogen receptor modulators (SERM) - ANSWER for
hormone receptor positive and advanced breast cancer. (Tamoxifin
reduces risk and recurrence risk)
Heart failure - ANSWER impairment of the ventricle to fill with or eject
blood; heart cannot meet metabolic need of the body.
CHF - ANSWER heart cannot keep up with metabolic needs; volume
overload in pulmonary area
Left Ventricular Dysfunction - ANSWER reduced ejection fraction;
ventricle having issue ejecting blood.
normal ejection fraction - ANSWER 55 - 60 % (blood pumped out with
each heartbeat)
Ejection fraction of 50% - reduced or preserved? - ANSWER preserved
Diastolic CHF - ANSWER preserved ejection fraction, problem is with
filling
Systolic CHF - ANSWER reduced ejection fraction, problem is with
ejecting
Left sided CHF - ANSWER pulmonary (JVD, fluid volume overload,
rails, S-3 murmurs) ** #1 cause of Right sided CHF
BNP - ANSWER gold standard lab test to diagnose CHF
Echocardiogram - ANSWER Diagnostic tool, evaluates heart structure
and function
, At Risk for HF - Stage A - ANSWER no structural heart disease or
symptoms of heart failure
Stage A HF co-morbidities - ANSWER htn, atherosclerotic disease,
diabetes, metabolic syndrome, patients using cardiotoxins with family
history
Therapy goals of stage A HF - ANSWER treat htn, encourage smoking
cessation, encourage regular exercise, treat lipid disorders, discourage
alcohol intake/drug use, control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes
(avapro, losartan, benicar, diovan, etc)
At Risk for HF - Stage B - ANSWER structural heart disease but no
symptoms of heart failure
Stage B HF co-morbidities - ANSWER previous MI, LV remodeling
with LV hypertrophy and low EF, asymptomatic valvular disease
Therapy goals of Stage B HF - ANSWER Meds: ACEI or ARB, Beta-
blockers, inplantable defibrillators
Stage C heart failure - ANSWER structural heart disease with prior or
current symptoms of HF
Presentation of Stage C HF - ANSWER known structural heart disease
and shortness of breath and fatigue, reduced exercise tolerance
Therapy for Stage C HF - ANSWER dietary salt restriction, MEDS:
diuretic, ACEI, beta blockers. Some patients: aldosterone antagonist,
ARBs, digitalis, hydralazine/nitrates, biventricular pacing, inplantable
defibrillators
Stage D heart failure - ANSWER refractory HF requiring specialized
interventions
Presentation of Stage D HF - ANSWER marked symptoms at rest despite
maximal medical therapy (recurrently hospitalized or cannot be safely
discharged without specialized interventions)
Therapy goals for Stage D HF - ANSWER compassionate end-of-life
care/hospice, extraordinary measures ,heart transplant, chronic inotropes,
permanent mechanical support, experimental drugs or surgery
, Ischemic heart Disease (CAD, MI) presentation - ANSWER chest
discomfort, pain in neck/jaw/chest (crushing, squeezing, sharp), pain
worse with exertion (demand requirement is higher), abnormal heart
sounds, hypoxia, arrhythmias (afib, ST elevation)
Stable angina goal - ANSWER decrease cardiac oxygen demand
Meds for stable angina - ANSWER nitro first choice, then beta blockers
(beta blockers if angina occurs with effort)
nitroglycerine dose - ANSWER sublingual, acts within 5 minutes, max
of 3 doses
Cardiac glycosides (Digoxin) - ANSWER Increased myocardial
contractile force (increases output), used in ED, exerts positive inotropic
action, can cause severe dysrhythmias
Digoxin Dosing - ANSWER therapeutic - 0.5-0.8 ng/ml. ASSESS apical
pulse before administering, If lethargic and not acting right, see patient
FIRST
Goal of Anticoagulant and Antiplatelet Drugs - ANSWER inactivate and
suppress formation of thrombin
Warfarin (coumadin) - ANSWER PO to prevent blood clots; start with
half a dose
Anticoagulants - ANSWER Warfarin, heparin, lovenox; Caution about
hemorrhage, any patients with risks for bleeding
Pneumonia Patho - ANSWER pathogen reaches airway and overwhelms
defenses causing inflammatory cascade; fluid forms, blocking diffusion
(gas exchange) causing hypoxia, ultimately leads to respiratory failure
Diagnosing pneumonia - ANSWER Chest X-ray: viral - diffuse
widespread whitening; bacterial - patchy, consolidated, lobar
Emphysema - ANSWER destruction of alveolar walls; air goes into
lungs, can't get out; leads to hyperinflation
Bronchitis - ANSWER excess mucus production, smooth muscle
hypertrophy